Drug class
Butyrophenone antipsychotic; dopamine and serotonin receptor antagonist
Mechanism of action
Has weak dopamine D2 receptor affinity relative to many conventional neuroleptics and modulates central dopaminergic, serotonergic and adrenergic signalling. Its atypical pharmacological profile is associated with antipsychotic and sedative effects with comparatively limited extrapyramidal effects in some studies.
General use cases
- Treatment of psychotic disorders and selected behavioural disturbances in countries where melperone remains authorised; exact indication depends on local product information.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
